1	Protein	protein	_	_	_	_	_	_	_
2	kinase	kinase	_	_	_	_	_	_	_
3	B	B	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	c-Akt	c-akt	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	phosphatidylinositol	phosphatidylinositol	_	_	_	_	_	_	_
9	3-kinase	3-kinase	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	STAT5	stat5	_	_	_	_	_	_	_
13	are	be	_	_	_	_	_	_	_
14	activated	activate	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	erythropoietin	erythropoietin	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	EPO	EPO	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	HCD57	hcd57	_	_	_	_	_	_	_
22	erythroid	erythroid	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	but	but	_	_	_	_	_	_	_
25	are	be	_	_	_	_	_	_	_
26	constitutively	constitutively	_	_	_	_	_	_	_
27	active	active	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	an	an	_	_	_	_	_	_	_
30	EPO-independent	epo-independent	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	apoptosis-resistant	apoptosis-resistant	_	_	_	_	_	_	_
33	subclone	subclone	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	HCD57-SREI	HCD57-SREI	_	_	_	_	_	_	_
36	cells	cell	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	erythropoietin	erythropoietin	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	EPO	EPO	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	stem	stem	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	factor	factor	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	SCF	SCF	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	activated	activate	_	_	_	_	_	_	_
16	protein	protein	_	_	_	_	_	_	_
17	kinase	kinase	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	EPO-dependent	epo-dependent	_	_	_	_	_	_	_
24	HCD57	HCD57	_	_	_	_	_	_	_
25	erythroid	erythroid	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	better	well	_	_	_	_	_	_	_
3	understand	understand	_	_	_	_	_	_	_
4	signals	signal	_	_	_	_	_	_	_
5	controlling	control	_	_	_	_	_	_	_
6	proliferation	proliferation	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	viability	viability	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	erythroid	erythroid	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	resist	resist	_	_	_	_	_	_	_
14	apoptosis	apoptosis	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	absence	absence	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	EPO	EPO	_	_	_	_	_	_	_
20	were	be	_	_	_	_	_	_	_
21	subcloned	subclone	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	characterized	characterize	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	HCD57-SREI	HCD57-SREI	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	)	)	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	activations	activation	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	STAT5a	STAT5a	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	STAT5b	STAT5b	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	noted	note	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	these	these	_	_	_	_	_	_	_
14	EPO-independent	epo-independent	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	PI3-kinase	PI3-kinase	_	_	_	_	_	_	_
2	activity	activity	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	upstream	upstream	_	_	_	_	_	_	_
6	activator	activator	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
9	because	because	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	PI3-kinase	PI3-kinase	_	_	_	_	_	_	_
12	inhibitor	inhibitor	_	_	_	_	_	_	_
13	LY294002	ly294002	_	_	_	_	_	_	_
14	blocked	block	_	_	_	_	_	_	_
15	both	both	_	_	_	_	_	_	_
16	constitutive	constitutive	_	_	_	_	_	_	_
17	PKB/Akt	pkb/akt	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	factor-dependent	factor-dependent	_	_	_	_	_	_	_
20	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
21	activity	activity	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	LY294002	ly294002	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	showed	show	_	_	_	_	_	_	_
5	that	that	_	_	_	_	_	_	_
6	proliferation	proliferation	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	viability	viability	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	both	both	_	_	_	_	_	_	_
11	HCD57-SREI	HCD57-SREI	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	HCD57	hcd57	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	correlated	correlate	_	_	_	_	_	_	_
16	with	with	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	activity	activity	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
21	;	;	_	_	_	_	_	_	_
22	however	however	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
25	activity	activity	_	_	_	_	_	_	_
26	alone	alone	_	_	_	_	_	_	_
27	did	do	_	_	_	_	_	_	_
28	not	not	_	_	_	_	_	_	_
29	protect	protect	_	_	_	_	_	_	_
30	these	these	_	_	_	_	_	_	_
31	cells	cell	_	_	_	_	_	_	_
32	from	from	_	_	_	_	_	_	_
33	apoptosis	apoptosis	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HCD57	hcd57	_	_	_	_	_	_	_
4	cells	cell	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	SCF	SCF	_	_	_	_	_	_	_
7	also	also	_	_	_	_	_	_	_
8	activated	activate	_	_	_	_	_	_	_
9	PKB/Akt	PKB/Akt	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	but	but	_	_	_	_	_	_	_
12	did	do	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	protect	protect	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	apoptosis	apoptosis	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	result	result	_	_	_	_	_	_	_
3	suggested	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	PKB/PI3-kinase	PKB/PI3-kinase	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	necessary	necessary	_	_	_	_	_	_	_
9	but	but	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	sufficient	sufficient	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	promote	promote	_	_	_	_	_	_	_
14	viability	viability	_	_	_	_	_	_	_
15	and/or	and/or	_	_	_	_	_	_	_
16	proliferation	proliferation	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Constitutive	constitutive	_	_	_	_	_	_	_
2	STAT5	STAT5	_	_	_	_	_	_	_
3	activity	activity	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	activated	activate	_	_	_	_	_	_	_
6	through	through	_	_	_	_	_	_	_
7	an	an	_	_	_	_	_	_	_
8	unknown	unknown	_	_	_	_	_	_	_
9	pathway	pathway	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	including	include	_	_	_	_	_	_	_
12	JAK2	jak2	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	EPOR	EPOR	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	may	may	_	_	_	_	_	_	_
17	act	act	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	concert	concert	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	constitutive	constitutive	_	_	_	_	_	_	_
23	PI3-kinase/PKB/Akt	PI3-kinase/PKB/Akt	_	_	_	_	_	_	_
24	pathway	pathway	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	protect	protect	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	EPO-independent	epo-independent	_	_	_	_	_	_	_
29	HCD57-SREI	HCD57-SREI	_	_	_	_	_	_	_
30	cells	cell	_	_	_	_	_	_	_
31	from	from	_	_	_	_	_	_	_
32	apoptosis	apoptosis	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	promote	promote	_	_	_	_	_	_	_
35	limited	limited	_	_	_	_	_	_	_
36	proliferation	proliferation	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

